The mission of our startup, founded in 2019, is to develop technology to treat and prevent currently untreatable virus and bacteria infections (as supported by PubMed, 2022).
These cause millions of deaths, immeasurable suffering and an economic impact of hundreds of billions of dollars every year.
With the aging population and the emergence of new antibiotic-resistant agents, this immense challenge grows faster every day.
We believe that scientific progress needs to translate into more health and quality of life for everyone.
PaccaTech is a Member of
At Pacca Tech, we tackle the pervasive global biofilm-related problems in the medical, veterinary, food & beverage, and naval markets, which cost up to $5,000 Bi (as reported by Nature, 2022).
With a diverse portfolio of patented technologies worldwide, we are committed to developing solutions that have a significant positive impact on the lives of as many people as possible.
Contact us to learn more about the innovative technology driving our Biosafety Start-up.
We are proud to be at the forefront of innovation with the development of the World's First clinically tested and certified non-Invasive device to prevent and treat currently untreatable post-surgery infections in metallic implants.
Our groundbreaking technology, MagClean©, when used for just 20-30 minutes daily, can effectively prevent the formation of implant biofilm, providing unparalleled protection against incurable post-surgery infections.
Join us in our mission to revolutionize implant care and improve patient outcomes.
"Healthy citizens are the greatest asset a country can have"